Form 4: Carlyle Group Sells Additional Shares of QuidelOrtho Corp (QDEL) Under 10b5-1 Trading Plan
SEC Form 4
Carlyle Group continues to reduce its stake in QuidelOrtho Corp through a pre-arranged Rule 10b5-1 trading plan.
Summary
- Carlyle Group Inc. and affiliated entities have sold shares of QuidelOrtho Corp (QDEL) on June 25 and June 26, 2024.
- The sales were executed under a Rule 10b5-1 trading plan adopted on May 12, 2024.
- A total of 41,299 shares were sold on June 25 at a weighted average price of $32.893, with prices ranging from $32.6905 to $32.9999.
- An additional 26,173 shares were sold on June 25 at a weighted average price of $33.1981, with prices ranging from $33.00 to $33.7555.
- On June 26, 17,568 shares were sold at a weighted average price of $32.8964, with prices ranging from $32.48 to $32.9998.
- Finally, 63,914 shares were sold on June 26 at a weighted average price of $33.2731, with prices ranging from $33.00 to $33.7741.
- Following these transactions, Carlyle Partners VI Cayman Holdings, L.P. beneficially owns 11,617,068 shares indirectly.
- Carlyle Group Inc. and related entities disclaim beneficial ownership of these securities.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the document primarily reports transactions under a pre-existing trading plan. There's no indication of positive or negative sentiment towards the company's future prospects.
Risks
- Continued sales by Carlyle Group could exert downward pressure on QDEL's stock price.
Future Outlook
The document does not provide specific forward-looking statements beyond the ongoing execution of the 10b5-1 trading plan.
Industry Context
The sale of shares by a major holder like Carlyle Group is a notable event that investors often monitor for insights into the company's prospects and the holder's investment strategy. It's common for large shareholders to use 10b5-1 plans to diversify their holdings or realize gains over time.
Stakeholder Impact
- The share sales could potentially impact shareholder value, depending on market perception and the volume of shares sold.
Key Dates
| Date | Description |
|---|---|
| 05/12/2024 | Date of adoption of the Rule 10b5-1 trading plan. |
| 06/25/2024 | Date of first reported transaction (share sales). |
| 06/26/2024 | Date of second reported transaction (share sales). |
| 06/27/2024 | Date of filing of the Form 4. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.